Algebris (Uk) LTD Genenta Science S.P.A. Transaction History
Algebris (Uk) LTD
- $321 Million
- Q4 2024
A detailed history of Algebris (Uk) LTD transactions in Genenta Science S.P.A. stock. As of the latest transaction made, Algebris (Uk) LTD holds 45,000 shares of GNTA stock, worth $175,500. This represents 0.06% of its overall portfolio holdings.
Number of Shares
45,000
Previous 45,000
-0.0%
Holding current value
$175,500
Previous $192,000
1.56%
% of portfolio
0.06%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding GNTA
# of Institutions
5Shares Held
360KCall Options Held
0Put Options Held
0-
Al Ti Global, Inc. New York, NY200KShares$781,1230.02% of portfolio
-
Allianz Se Munich, 2M103KShares$402,6750.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il11.2KShares$43,5510.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Genenta Science S.p.A.
- Ticker GNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,216,900
- Market Cap $71M
- Description
- Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...